OPTOMED Stock Overview
Manufactures and sells handheld fundus cameras in Finland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Optomed Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.17 |
| 52 Week High | €7.74 |
| 52 Week Low | €3.26 |
| Beta | 2.24 |
| 1 Month Change | 5.31% |
| 3 Month Change | -18.97% |
| 1 Year Change | 17.99% |
| 3 Year Change | -58.27% |
| 5 Year Change | -34.72% |
| Change since IPO | -9.06% |
Recent News & Updates
Recent updates
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Sep 27
Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63
May 11Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost
May 10Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost
Mar 22Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Feb 18Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues
Dec 21Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?
Nov 15Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts
Aug 09Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)
Jun 01Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?
Oct 27Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?
Apr 23Shareholder Returns
| OPTOMED | FI Medical Equipment | FI Market | |
|---|---|---|---|
| 7D | -10.7% | -0.9% | -2.4% |
| 1Y | 18.0% | 4.7% | -8.4% |
Return vs Industry: OPTOMED exceeded the Finnish Medical Equipment industry which returned 4.7% over the past year.
Return vs Market: OPTOMED exceeded the Finnish Market which returned -8.4% over the past year.
Price Volatility
| OPTOMED volatility | |
|---|---|
| OPTOMED Average Weekly Movement | 9.2% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in FI Market | 7.6% |
| 10% least volatile stocks in FI Market | 2.8% |
Stable Share Price: OPTOMED's share price has been volatile over the past 3 months compared to the Finnish market.
Volatility Over Time: OPTOMED's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Finnish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 113 | Juho Himberg | www.optomed.com |
Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions.
Optomed Oyj Fundamentals Summary
| OPTOMED fundamental statistics | |
|---|---|
| Market cap | €81.62m |
| Earnings (TTM) | -€5.99m |
| Revenue (TTM) | €13.60m |
6.0x
P/S Ratio-13.6x
P/E RatioIs OPTOMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OPTOMED income statement (TTM) | |
|---|---|
| Revenue | €13.60m |
| Cost of Revenue | €4.79m |
| Gross Profit | €8.81m |
| Other Expenses | €14.80m |
| Earnings | -€5.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 64.80% |
| Net Profit Margin | -44.04% |
| Debt/Equity Ratio | 10.6% |
How did OPTOMED perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Optomed Oyj is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Juha Kinnunen | Inderes Oy |
| Gergana Almquist | Redeye |